Dataset Information


Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2.

ABSTRACT: Activation of the angiotensin 1-7/Mas receptor (MasR) axis counteracts angiotensin II (Ang II)-mediated cardiovascular disease. Recombinant human angiotensin-converting enzyme 2 (rhACE2) generates Ang 1-7 from Ang II. We hypothesized that the therapeutic effects of rhACE2 are dependent on Ang 1-7 action. Wild type male C57BL/6 mice (10-12 weeks old) were infused with Ang II (1.5 mg/kg/d) and treated with rhACE2 (2 mg/kg/d). The Ang 1-7 antagonist, A779 (200 ng/kg/min), was administered to a parallel group of mice. rhACE2 prevented Ang II-induced hypertrophy and diastolic dysfunction while A779 prevented these beneficial effects and precipitated systolic dysfunction. rhACE2 effectively antagonized Ang II-mediated myocardial fibrosis which was dependent on the action of Ang 1-7. Myocardial oxidative stress and matrix metalloproteinase 2 activity was further increased by Ang 1-7 inhibition even in the presence of rhACE2. Activation of Akt and endothelial nitric oxide synthase (eNOS) by rhACE2 were suppressed by the antagonism of Ang 1-7 while the activation of pathological signaling pathways was maintained. Blocking Ang 1-7 action prevents the therapeutic effects of rhACE2 in the setting of elevated Ang II culminating in systolic dysfunction. These results highlight a key cardioprotective role of Ang 1-7, and increased Ang 1-7 action represents a potential therapeutic strategy for cardiovascular diseases.Activation of the renin-angiotensin system (RAS) plays a key pathogenic role in cardiovascular disease. ACE2, a monocarboxypeptidase, negatively regulates pathological effects of Ang II. Antagonizing Ang 1-7 prevents the therapeutic effects of recombinant human ACE2. Our results highlight a key protective role of Ang 1-7 in cardiovascular disease.


PROVIDER: S-EPMC4580513 | BioStudies | 2015-01-01

REPOSITORIES: biostudies

Similar Datasets

2010-01-01 | S-EPMC2827767 | BioStudies
2016-01-01 | S-EPMC4908402 | BioStudies
2018-01-01 | S-EPMC6613216 | BioStudies
2010-01-01 | S-EPMC2809962 | BioStudies
2015-01-01 | S-EPMC4692500 | BioStudies
2016-01-01 | S-EPMC4939482 | BioStudies
2015-01-01 | S-EPMC4807023 | BioStudies
2019-01-01 | S-EPMC6831892 | BioStudies
2016-01-01 | S-EPMC4748536 | BioStudies
2015-01-01 | S-EPMC4314638 | BioStudies